Combatting Antimicrobial Resistance (AMR) and the AMR Challenge

Discover why BIOMIN has committed to the AMR Challenge.

Dr. Jan Vanbrabant, Managing Director of BIOMIN and Executive Board Chairman of ERBER Group, explains how “in order to preserve the medicinal value of antibiotics, we need to use less of them. That means using alternatives to promote growth and maintain healthy animals.”